ROCHE RECEIVES FDA CLEARANCE FOR ELECSYS® PTAU217, ADVANCING ALZHEIMER'S DISEASE ASSESSMENT ACROSS PRIMARY AND SPECIALTY CARE

Reuters · 2d ago

Please log in to view news